[1] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359
[2] Nie Y, Wu K, Yu J, et al, A global burden of gastric cancer: the major impact of China[J]. Expert Rev Gastroenterol Hepatol, 2017, 11(7): 651
[3] Kuhn S, Geyer M. Formins as effector proteins of Rho GTPases[J]. Small GTPases, 2014, 5(3): e29513
[4] Faix J, Grosse R. Staying in shape with formins[J]. Dev Cell, 2006, 10(6): 693
[5] Yang S S, Li X M, Yang M ,et al. FMNL2 destabilises COMMD10 to activate NF-kB pathway in invasion and metastasis of colorectal cancer[J]. Br J Cancer, 2017, 117(8): 1164
[6] Zhu X L, Zeng Y F, Guan J, et al. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma[J]. J Pathol, 2011, 224(3): 377
[7] Torre L A, Siegel R L, Ward E M, et al. Global cancer incidence and mortality rates and trends--an update[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(1): 16
[8] Lizarraga F, Poincloux R, Romao M, et al. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells[J]. Cancer Res, 2009, 69(7): 2792
[9] Ren X L, Qiao Y D, Li J Y, et al. Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation[J]. Cancer Lett, 2018, 419: 245
[10] Gardberg M, Talvinen K, Kaipio K, et al. Characterization of Diaphanous-related formin FMNL2 in human tissues[J]. BMC Cell Biol, 2010, 11: 55
[11] Péladeau C, Heibein A, Maltez M T, et al. A specific FMNL2 isoform is up-regulated in invasion cells[J]. BMC Cell Biol, 2016, 17(1): 32
[12] Katoh M, Katoh M. Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico[J]. Int J Oncol, 2003, 22(5): 1161
[13] Yan Y, Wang Z, Qin B, et al. A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC[J]. Biochem Biophys Res Commun, 2019, 509(2): 441
[14] Zhu X L, Liang L, Ding Y Q. Overexpression of FMNL2 is closely related to metastasis of colorectal cancer[J]. Int J Colorectal Dis, 2008, 23(11): 1041
[15] Liang L, Guan J, Zeng Y, et al. Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma[J]. Hum Pathol, 2011, 42(11): 1603
[16] Zhong B, Wang K, Xu H, et al. Silencing Formin-like 2 inhibits growth and metastasis of gastric cancer cells through suppressing internalization of integrins[J]. Cancer Cell Int, 2018, 18: 79
[17] Gardberg M, Heuser V D, Koskivuo I, et al. FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome[J]. J Pathol Clin Res, 2016, 2(1): 41
[1]刘新兰,李淑璟,张海霞.候选抑癌基因RASSF6在胃癌组织中的表达及其与临床病理特征的关系[J].天津医科大学学报,2015,21(04):287.
LIU Xin -lan,LI Shu -jing,ZHANG Hai -xia.Expressions of RASSF6 in gastric cancer and its association with clinicopathologic feature[J].Journal of Tianjin Medical University,2015,21(02):287.
[2]李 静,孙保存,孙 冉,等.环氧合酶2通过上皮间质转换促进胃癌的侵袭与转移 [J].天津医科大学学报,2016,22(03):185.
LI Jing,SUN Bao-cun,SUN Ran,et al.Cyclooxygenase-2 promotes gastric cancer invasion and metastasis by inducing epithelial to mesenchymal transition[J].Journal of Tianjin Medical University,2016,22(02):185.
[3]郭江涛综述,邓靖宇审校.胃癌淋巴结转移的分子标志物研究进展[J].天津医科大学学报,2017,23(01):85.
[4]赵忠治,王金淼,魏颖,等.术前外周血NLR与PLR对胃癌预后的评估价值[J].天津医科大学学报,2018,24(01):50.
ZHAO Zhong-zhi,WANG Jin-miao,WEI Ying,et al.Evaluation value?of preoperative peripheral blood NLR and PLR? on prognosis of? gastric cancer[J].Journal of Tianjin Medical University,2018,24(02):50.
[5]张 悦,管叙文,王婧雅,等.miR-27a对胃癌细胞凋亡影响的体外研究[J].天津医科大学学报,2018,24(06):469.
ZHANG Yue,GUAN Xu-wen,WANG Jing-ya,et al.Influence of miR-27a on apoptosis of gastric cancer cells in vitro[J].Journal of Tianjin Medical University,2018,24(02):469.
[6]白惠惠,邓靖宇,梁 寒.血清肿瘤标志物对胃癌淋巴结转移的诊断价值[J].天津医科大学学报,2019,25(03):241.
BAI Hui-hui,DENG Jing-yu,LIANG Han.Prognostic value of serum tumor biomarkers for lymph node metastasis of gastric cancer[J].Journal of Tianjin Medical University,2019,25(02):241.
[7]赵珍珍 综述,邓靖宇 审校.蛋白质组学技术在胃癌研究中的应用[J].天津医科大学学报,2021,27(01):94.
[8]昕宇 综述,邓靖宇,梁寒 审校.主动脉旁淋巴结清扫术在进展期胃癌治疗中的研究进展[J].天津医科大学学报,2021,27(01):99.
[9]左兴盛,宋志玉,贾海盼,等.沉默circPVT1对5-氟尿嘧啶耐药胃癌细胞化疗增敏作用及机制研究[J].天津医科大学学报,2021,27(06):574.
ZUO Xing-sheng,SONG Zhi-yu,JIA Hai-pan,et al.The sensitizing effect and mechanism of silencing of circPVT1 on 5-fluorouracil chemosensitivity in gastric cancer cells[J].Journal of Tianjin Medical University,2021,27(02):574.
[10]赵路瑶 综述,李慕然,刘艳迪 审校.外周血SEPT9基因甲基化检测在胃癌诊断中的研究进展[J].天津医科大学学报,2022,28(02):218.